The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Cancer related inflammation: The macrophage connection
Abstract
Tumor-associated macrophages (TAM) are key regulators of the link between inflammation and cancer. In the tumor microenvironment neoplastic cells shape the differentiation and functional orientation of TAM which, in turn, express several protumoral functions, including secretion of growth factors and matrix-proteases, promotion of angiogenesis and suppression of adaptive immunity. This review analyzes our current knowledge of TAM and their involvement in tumor development and progression. The interplay between TAM and neoplastic cells represents a promising target of future therapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationAngiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 601
Multifunctional nanoparticles for targeting cancer and inflammatory diseases
Jain, S., Doshi, A. S., Iyer, A. K., & Amiji, M. M. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.832769 · Cited by 27
Jiang, Y., Li, S., Jiang, L., Mu, G., & Jiang, S. (2024) · Journal of Dairy Science · doi:10.3168/jds.2024-25224 · Cited by 25
Huang, W., Yuan, H., Yang, H., Shen, Y., Guo, L., Zhong, N., Wu, T. S., Shen, Y., Chen, G., Huang, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202410703 · Cited by 26
Montani, M. S. G., Benedetti, R., Piconese, S., Pulcinelli, F. M., Timperio, A. M., Romeo, M. A., Masuelli, L., Mattei, M., Bei, R., D’Orazi, G., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0699 · Cited by 28
Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors
Wilczyński, J. R., & Nowak, M. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_1 · Cited by 27
Tunalı, G., Yanık, H., Öztürk, S. C., Canlı, S. D., Efthymiou, G., Yılmaz, K. B., Obberghen‐Schilling, E. V., & Esendağlı, G. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01629-0 · Cited by 27
Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer
Mardente, S. (2010) · Oncology Reports · doi:10.3892/or_00001005 · Cited by 26
Nakamura, Y., Sugita, Y., Nakashima, S., Okada, Y., Yoshitomi, M., Kimura, Y., Miyoshi, H., Morioka, M., & Ohshima, K. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.11.034 · Cited by 24
Tumor Immune Microenvironment in Gynecologic Cancers
Margul, D. J., Yu, C., & AlHilli, M. M. (2023) · Cancers · doi:10.3390/cancers15153849 · Cited by 24
Zhang, W., Hu, Y., He, J., Guo, D., Zhao, J., & Li, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691995 · Cited by 25
Mahajna, J. A. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000361 · Cited by 25
Choi, Y. J., Oh, S.-G., Singh, T. D., Ha, J., Kim, D. W., Lee, S. W., Jeong, S. Y., Ahn, B., Lee, J., & Jeon, Y. H. (2016) · Neoplasia · doi:10.1016/j.neo.2016.01.004 · Cited by 25
Misra, P., & Singh, S. (2019) · Cancer Medicine · doi:10.1002/cam4.2112 · Cited by 25
MiR‐146b Mediates Endotoxin Tolerance in Human Phagocytes
Renzi, T. A., Rubino, M., Gornati, L., Garlanda, C., Locati, M., & Curtale, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/145305 · Cited by 25
C5aR deficiency attenuates the breast cancer development via the p38/p21 axis
Chen, J., Sun, Z.-H., Chen, L., Xu, F., Zhao, Y., Li, G.-Q., Tang, M., Li, Y., Zheng, Q., Wang, S., et al. (2020) · Aging · doi:10.18632/aging.103468 · Cited by 24
Ren, S., Zhang, X., Hu, Y., Wu, J., Ju, Y., Sun, X., Liu, Y., & Shan, B. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3881 · Cited by 24
Lessons from Cancer Immunoediting in Cutaneous Melanoma
Aris, M., Barrio, M. M., & Mordoh, J. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/192719 · Cited by 25
Exploiting the tumor microenvironment for theranostic imaging
Stasinopoulos, I. A., Penet, M., Chen, Z., Kakkad, S. M., Glunde, K., & Bhujwalla, Z. M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1664 · Cited by 24
Li, B., Yuan, J., & Wu, J. (2021) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00743 · Cited by 23
Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's Perspective
Ch’ng, E. S., Jaafar, H., & Sharif, S. E. T. (2011) · Pathology Research International · doi:10.4061/2011/572706 · Cited by 23
Andersen, M. N., Ludvigsen, M., Abildgaard, N., Petruskevicius, I., Hjortebjerg, R., Bjerre, M., Honoré, B., Møller, H. J., & Andersen, N. F. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s124321 · Cited by 22
Zhang, X., Zhu, M., Hong, Z., & Chen, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1256 · Cited by 23
Zhang, L.-N., Xiao, W., OuYang, P., You, K., Zeng, Z., Ding, P.-R., Pan, Z.-Z., Xu, R., & Gao, Y.-H. (2015) · Tumor Biology · doi:10.1007/s13277-015-3560-6 · Cited by 23
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Mathiesen, H., Juul‐Madsen, K., Tramm, T., Vorup‐Jensen, T., Møller, H. J., Etzerodt, A., & Andersen, M. N. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.106970 · Cited by 23
Wang, C., Lin, R., Hsu, H., & Tseng, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271790 · Cited by 22
Hu, H., Qi, L., Ren, C., & Yan, S. (2022) · The Heart Surgery Forum · doi:10.1532/hsf.4919 · Cited by 22
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
Filiberti, S., Russo, M., Lonardi, S., Bugatti, M., Vermi, W., Tournier, C., & Giurisato, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112709 · Cited by 25
Macrophages — Masters of Immune Activation, Suppression and Deviation
Foey, A. (2014) · InTech eBooks · doi:10.5772/57541 · Cited by 24
Japink, D., Leers, M. P. G., Sosef, M. N., & Nap, M. (2009) · PubMed · Cited by 22
CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis
van Attekum, M. H. A., van Bruggen, J. A. C., Slinger, E., Lebre, M. C., Reinen, E., Kersting, S., Eldering, E., & Kater, A. P. (2017) · Haematologica · doi:10.3324/haematol.2016.157206 · Cited by 22
Przybył, J., Kozak, K., Koseła-Paterczyk, H., Falkowski, S., Świtaj, T., Ługowska, I., Szumera‐Ciećkiewicz, A., Ptaszyński, K., Grygalewicz, B., Chechlińska, M., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0109-2 · Cited by 22
Interactions between platelets and the cancer immune microenvironment
Tuerhong, N., Yang, Y., Wang, C., Huang, P., & Li, Q. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104380 · Cited by 21
Wang, Y., Chen, C.-Y., Lei, L., & Zhang, Y. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123373 · Cited by 22
Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
Zhong, S., Huang, C., Chen, Z., Chen, Z., & Luo, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215000 · Cited by 20
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
Sharma, A. K., & Giri, A. K. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1309175 · Cited by 23
Atılgan, A. O., Özdemir, B. H., Akçay, E. Y., Demirkan, Ö. A., Tekindal, M. A., & Özkardeş, H. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.10.011 · Cited by 21
Zhou, K., Taoerdahong, H., Bai, J., Bakasi, A., Wang, X., & Dong, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.146 · Cited by 21
Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia
Tavares, P., Moreira‐Gonçalves, D., Santos, L. L., & Ferreira, R. M. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000123 · Cited by 20
Zhang, X., Shi, X., Zhao, H., Jia, X., & Yang, Y. (2021) · BioMed Research International · doi:10.1155/2021/8864436 · Cited by 20
The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
Zhang, J., Li, R., & Huang, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.951019 · Cited by 19
Watanabe, R., Tomita, N., Kishimoto, K., Koyama, S., Ogusa, E., Ishii, Y., Miyashita, K., Matsuura, S., Fujisawa, S., Hattori, Y., et al. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.015 · Cited by 20
Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients
Mao, H., Pan, F., Guo, H., Bu, F., Xin, T., Chen, S., & Guo, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5085-z · Cited by 20
Zhang, J., Chen, L., Zhou, R., Sun, H., Liao, Y., & Liao, W. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/9801063 · Cited by 19
Xia, H.-F., Zhu, J., Wang, J., Ren, J., Cai, Y., Wang, F., Zhang, W., Chen, G., Zhao, Y., & Zhao, J. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417694872 · Cited by 20
Cho, H., Kim, S. H., Kim, S., Chang, J. H., Yang, W. I., Suh, C., Cheong, J., Kim, Y. R., Lee, J. Y., Jang, J. E., et al. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3014-x · Cited by 21
Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression
Foster, H., Ulasov, I. V., & Cobbs, C. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.006 · Cited by 20
Xin, W., Huang, C., Zhang, X., Zhang, G., Ma, X., Sun, L., Wang, C., Zhang, D., Zhang, T., & Du, G. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.11.014 · Cited by 20
Shi, Y., Yasui, M., & Hara‐Chikuma, M. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101317 · Cited by 18
Magnetic nanoparticles and possible synergies with cold atmospheric plasma for cancer treatment
Dai, X., Dai, Y., Zheng, Y., & Lv, Y. (2024) · RSC Advances · doi:10.1039/d4ra03837a · Cited by 19
Carboxypeptidase M in apoptosis, adipogenesis and cancer
Denis, C. J., Deiteren, K., Hendriks, D. F., Proost, P., & Lambeir, A. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.11.012 · Cited by 19
Many Roles of CCL20: Emphasis on Breast Cancer
Osuala, K. O., & Sloane, B. F. (2014) · Postdoc Journal · doi:10.14304/surya.jpr.v2n3.2 · Cited by 19
Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing
Zins, K., & Abraham, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_17 · Cited by 21
Jin, Y., Yu, G., Hu, P., Yang, C., Li, X., Chen, X., Wei, Q., & Wang, J. (2020) · Immunologic Research · doi:10.1007/s12026-020-09155-3 · Cited by 23
Chagovets, V., Starodubtseva, N. L., Tokareva, A., Novoselova, A., Patysheva, M. R., Larionova, I., Prostakishina, E. A., Rakina, M. A., Казакова, А., Topolnitskiy, E. B., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1332043 · Cited by 19
Mechanisms underlying aryl hydrocarbon receptor-driven divergent macrophage function
Malany, K., Li, X., Vogel, C. F. A., & Ehrlich, A. K. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae050 · Cited by 18
Zhu, F., Li, X., Jiang, Y. Q., Zhu, H., Zhang, H., Zhang, C., Zhao, Y., & Luo, F. (2015) · Oncology Reports · doi:10.3892/or.2015.4268 · Cited by 18
Fan, H., Li, L., Zhang, Y.-M., Yang, J., Li, M.-C., Zeng, F., & Deng, F. (2017) · Tumor Biology · doi:10.1177/1010428317701442 · Cited by 18
Bernal, M., Concha, Á., Sáenz-López, P., Rodríguez, A. I. E., Cabrera, T., Garrido, F., & Ruiz‐Cabello, F. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0999-1 · Cited by 19
Activation of Murine Macrophages
Mosser, D. M., & Gonçalves, R. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im1402s111 · Cited by 18
Kumari, A., Syeda, S., Rawat, K., Kumari, R., & Shrivastava, A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02676-2 · Cited by 17
Faber, T. J. E., Japink, D., Leers, M. P. G., Sosef, M. N., MEYENFELDT, M. F. V., & Nap, M. (2011) · Tumor Biology · doi:10.1007/s13277-011-0269-z · Cited by 17
Inhibition of blood vessel formation in tumors by IL ‐18‐polarized M1 macrophages
Xing, Y., Tian, Y., Kurosawa, T., Matsui, S., Touma, M., Wu, Q., & Sugimoto, K. (2016) · Genes to Cells · doi:10.1111/gtc.12329 · Cited by 17
Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin
Guttman, O., Freixo-Lima, G. S., Kaner, Z., Lior, Y., Rider, P., & Lewis, E. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00559 · Cited by 17
Wang, X., Shen, Y., MengLv, L., Zhang, X., Yang, J., Wang, F., & Yang, J. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105302 · Cited by 17
Cho, H.-D., Brownmiller, C., Sorker, H., Islam, S., & Lee, S. (2021) · Foods · doi:10.3390/foods10092051 · Cited by 14
Küçük, A., Topkan, E., Özkan, E. E., Öztürk, D., Pehlivan, B., & Selek, U. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231187759 · Cited by 16
Function and clinical application of exosome—how to improve tumor immunotherapy?
Qin, S., Cao, J., & Ma, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228624 · Cited by 16
Identification of potential therapeutic targets for lung cancer by bioinformatics analysis
WANG, L.-Q., ZHAO, L.-H., & Qiao, Y.-Z. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4752 · Cited by 16
Tao, Z., Li, S. X., Cui, X., Huang, Y., Zhu, S., Wang, Y., Tan, H., & Ma, X. (2018) · Cancer Biomarkers · doi:10.3233/cbm-181230 · Cited by 16
Forkhead Box Q1 Is Critical to Angiogenesis and Macrophage Recruitment of Colorectal Cancer
Tang, H., Zheng, J. Y., Bai, X., Yue, K.-L., Liang, J., Li, D., Wang, L., Wang, J., & Guo, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.564298 · Cited by 16
Liang, D.-S., Wen, Z.-J., Wang, J.-H., Zhu, F.-F., Guo, F., Zhou, J.-L., Xu, J.-J., & Zhong, H.-J. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1906886 · Cited by 15
Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma
Liu, J., Wang, L., Wang, T., & Wang, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9145 · Cited by 16
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.893311 · Cited by 16
Chronic inflammation and gastrointestinal cancer
Watanabe, M., Ida, S., & Baba, H. (2015) · Journal of Cancer Metastasis and Treatment · doi:10.4103/2394-4722.166994 · Cited by 17
Qualls, J. E., & Murray, P. J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00010-3 · Cited by 15
Interaction of Immune and Cancer Cells
Klink, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4 · Cited by 15
Qi, Y., Sun, D., Yang, W., Xu, B., Lv, D., Han, Y., Sun, M., Jiang, S., Hu, W., & Yang, Y. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.03.010 · Cited by 15
Wang, L.-A., Yang, B., Tang, T., Yang, Y., Zhang, D., Xiao, H., Xu, J., Wang, L., Lin, L. W., & Jiang, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11814 · Cited by 15
Lim, H., Park, J., Abekura, F., Choi, H., Kim, H.-D., Magae, J., Chang, Y., Lee, Y., & Kim, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107184 · Cited by 14
M2a macrophages induce contact-dependent dispersion of carcinoma cell aggregates
(2016) · Macrophage · doi:10.14800/macrophage.1222 · Cited by 14
Jiménez-García, L., Herranz, S., Higueras, M. Á., Luque, A., & Hortelano, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11652 · Cited by 14
Song, J., Lai, X., Zhang, Y., Zheng, X., & Su, J. (2019) · Medicine · doi:10.1097/md.0000000000017818 · Cited by 14
Chen, L., Zeng, H., Du, Z., Zhao, Y., & Ma, X. (2020) · Cancer Biomarkers · doi:10.3233/cbm-201739 · Cited by 14
Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis
Wang, Y., Liu, Y., Xiang, L., Han, L., Yao, X., Hu, Y., & Wu, F. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211038511 · Cited by 12
Human-derived Tumor-On-Chip model to study the heterogeneity of breast cancer tissue
Jeibouei, S., Monfared, A. K., Hojat, A., Aref, A. R., Shams, F., Dolati, M., Moradi, A., Hosseini, M., Javadi, S. M. R., Ajoudanian, M., et al. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213915 · Cited by 15
Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies
Jóźwik, M., Okungbowa, O. E., Lipska, A., Jóźwik, M., Smoktunowicz, M., Semczuk, A., Jóźwik, M., & Radziwon, P. (2015) · BMC Cancer · doi:10.1186/s12885-015-1136-x · Cited by 14
Chawla, H., Urs, A. B., & Augustine, J. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000284 · Cited by 14
Li, G., Ji, J., Yang, F., Xu, H., & Bai, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s110411 · Cited by 13
Nicolini, A., Ferrari, P., Diodati, L., & Carpi, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092733 · Cited by 14
Toh, B., Toh, B., Abastado, J., & Abastado, J. (2012) · OncoImmunology · doi:10.4161/onci.22196 · Cited by 15
Argyle, D. J., & Khanna, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2362-5.00002-5 · Cited by 14
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer
Iuliano, S., Mirabelli, M., Giuliano, S., & Brunetti, A. (2025) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001202 · Cited by 13
Zajac, K. K., Malla, S., Babu, R. J., Raman, D., & Tiwari, A. K. (2023) · Cancer Reports · doi:10.1002/cnr2.1779 · Cited by 13
Macrophage Polarisation: A collaboration of Differentiation, Activation and Pre-Programming?
Foey, A. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000293 · Cited by 13
Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
Ye, W., Li, M., & Luo, K.-W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071788 · Cited by 14
Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer
Mukaida, N., Sasakki, S.-I., & Popivanova, B. K. (2011) · Cancers · doi:10.3390/cancers3032811 · Cited by 13
Chang, H., Ni, Y., Shen, C., Li, C., He, K., Zhu, X., Chen, L., Chen, L., Qiu, J., Ji, Y., et al. (2022) · Immunology · doi:10.1111/imm.13519 · Cited by 12
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer
Chen, F., Chen, R., Fang, W., Gao, X., Ying, H., Zheng, X., Chen, L., & Jiang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1144330 · Cited by 12
Mutation-specific effects of NRAS oncogenes in colorectal cancer cells
Kuhn, N. R., Klinger, B., Uhlitz, F., Sieber, A., Rivera, M., Klotz‐Noack, K., Fichtner, I., Hoffmann, J., Blüthgen, N., Falk, C. S., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100778 · Cited by 13
Pramudya, M., Dewi, F. R. P., Wong, R. W.-C., Anggraini, D. W., Winarni, D., & Wahyuningsih, S. P. A. (2022) · Veterinary World · doi:10.14202/vetworld.2022.1177-1184 · Cited by 12
Metadata
- Authors
- Sica, A., Allavena, P., & Mantovani, A.
- Affiliations
- Fondazione Humanitas per la Ricerca (IT)
- University of Milan (IT)
- Corresponding author
- Allavena, Paola
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 267
- Issue
- 2
- Pages
- 204-215
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2141487097
- Cited by
- 601
- References
- 96
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 22 · 2023: 36 · 2022: 30 · 2021: 36 · 2020: 36 · 2019: 30 · 2018: 29 · 2017: 39 · 2016: 32 · 2015: 35 · 2014: 47 · 2013: 35 · 2012: 37
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor inflammation, tumor microenvironment, macrophage polarization, tumor progression, angiogenesis, immunosuppression, growth factors, carcinogenesis, therapeutic target
- MeSH terms
- Animals, Humans, Inflammation, Macrophage Activation, Macrophages, Neoplasms, NF-kappa B, Cell Polarity, Disease Progression, STAT3 Transcription Factor, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review